Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies.

Reguera J, Santiago C, Mudgal G, Ordoño D, Enjuanes L, Casasnovas JM.

PLoS Pathog. 2012;8(8):e1002859. doi: 10.1371/journal.ppat.1002859. Epub 2012 Aug 2.

2.

Further characterization of aminopeptidase-N as a receptor for coronaviruses.

Delmas B, Gelfi J, Sjöström H, Noren O, Laude H.

Adv Exp Med Biol. 1993;342:293-8.

PMID:
7911642
3.
5.
6.

Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.

Dietrich MH, Ogden KM, Katen SP, Reiss K, Sutherland DM, Carnahan RH, Goff M, Cooper T, Dermody TS, Stehle T.

J Virol. 2017 Jan 31;91(4). pii: e01621-16. doi: 10.1128/JVI.01621-16. Print 2017 Feb 15.

7.

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.

Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.

MAbs. 2010 Jan-Feb;2(1):53-66. Epub 2010 Jan 27.

8.

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD.

J Virol. 2005 Mar;79(5):2678-88.

9.

Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein.

Reguera J, Ordoño D, Santiago C, Enjuanes L, Casasnovas JM.

J Gen Virol. 2011 May;92(Pt 5):1117-26. doi: 10.1099/vir.0.027607-0. Epub 2011 Jan 12.

10.

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.

van den Brink EN, Ter Meulen J, Cox F, Jongeneelen MA, Thijsse A, Throsby M, Marissen WE, Rood PM, Bakker AB, Gelderblom HR, Martina BE, Osterhaus AD, Preiser W, Doerr HW, de Kruif J, Goudsmit J.

J Virol. 2005 Feb;79(3):1635-44.

11.
12.
15.

Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody.

Ng OW, Keng CT, Leung CS, Peiris JS, Poon LL, Tan YJ.

PLoS One. 2014 Jul 14;9(7):e102415. doi: 10.1371/journal.pone.0102415. eCollection 2014.

16.

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Sui J, Deming M, Rockx B, Liddington RC, Zhu QK, Baric RS, Marasco WA.

J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.

19.

Porcine deltacoronavirus engages the transmissible gastroenteritis virus functional receptor porcine aminopeptidase N for infectious cellular entry.

Wang B, Liu Y, Ji CM, Yang YL, Liang QZ, Zhao P, Xu LD, Lei XM, Luo WT, Qin P, Zhou J, Huang YW.

J Virol. 2018 Apr 4. pii: JVI.00318-18. doi: 10.1128/JVI.00318-18. [Epub ahead of print]

PMID:
29618640
20.

Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.

Zhang X, Wang J, Wen K, Mou Z, Zou L, Che X, Ni B, Wu Y.

Viral Immunol. 2009 Dec;22(6):407-15. doi: 10.1089/vim.2009.0046.

PMID:
19951177

Supplemental Content

Support Center